Archives
-
TSSK2 Inhibitors: Pyrimidine and Pyrrolopyrimidine Findings
2026-10-05
Hawkinson and colleagues reported a mobility-shift high-throughput screen that identified potent pyrrolopyrimidine and pyrimidine inhibitors of the reproductive kinase TSSK2. The study established sub-100-nanomolar biochemical inhibitors, including a compound with dual TSSK1/TSSK2 activity and reduced metabolic-liability concerns, while also defining important limits for translating enzyme potency into contraceptive efficacy.
-
In Vivo CAR T Cells for Lupus: Evidence and Limits
2026-10-05
A source-grounded overview of a 2026 mouse study evaluating in vivo generation of CD19-directed CAR T cells for systemic lupus erythematosus. The article explains the research context, reported immune and tissue outcomes, comparison with antibody-based and ex vivo CAR T approaches, and the major limitations affecting interpretation. It also clarifies that the supplied study does not identify the HyperScribe™ kit or establish that a commercial mRNA synthesis product was used.
-
Protease Inhibitor Cocktails: Evidence and Limits
2026-10-04
A source-grounded overview of how protease inhibitor cocktails may support protein stability in plant extracts, how to assess supplier claims, and why findings from TBK1–itaconic acid research should not be overextended across biological systems.
-
AEBSF.HCl and the Next Protease Question
2026-10-03
AEBSF.HCl offers a strategic way to interrogate serine-protease-dependent biology without confusing it with the cathepsin-driven lysosomal axis implicated in MLKL-associated necroptosis. This perspective connects protease mechanism, amyloid processing, cell-lysis studies, and translational evidence boundaries.
-
Polybrene: Reliable Transduction Workflows
2026-10-02
This scenario-based guide explains how Polybrene (Hexadimethrine Bromide) 10 mg/mL, SKU K2701, can help stabilize viral transduction and difficult lipid-mediated DNA transfection workflows without obscuring cell-toxicity effects. It provides practical controls, storage guidance, assay interpretation, and a candid framework for comparing reagent formats.
-
EZ Cap™ Mouse CD252(OX40L) mRNA (m1Ψ, HA tag)
2026-10-01
R1078 enables controlled, transient display of mouse OX40L for mechanistic co-stimulation studies, with an HA tag that supports orthogonal expression checks. This guide separates directly supported product use from insights translated from CD80 and 4-1BBL mRNA work, then provides a practical workflow for assay design, optimization, and troubleshooting.
-
BIBR 1532: Telomerase Inhibitor Workflows
2026-10-01
Build a reproducible telomerase inhibition workflow with BIBR 1532, from concentration-response testing to orthogonal apoptosis and telomere-maintenance readouts. Its non-nucleosidic hTERT mechanism also provides a useful comparator for DNA-damage and telomere-attrition combinations in leukemia and solid-tumor models.
-
LRPPRC–Dasatinib Dual OXPHOS Disruption
2026-09-30
A 2026 study identified dasatinib as a synergistic partner for LRPPRC inhibition in OXPHOS-dependent cancer models. Its central mechanistic insight is that the combination blocks mitochondrial and nuclear OXPHOS programs in parallel, providing a rationale for dual-genome metabolic targeting while highlighting important translational questions.
-
Protease Inhibitor Cocktail: Assay Workflow Guide
2026-09-30
Learn how an EDTA-free inhibitor blend can protect protein extracts for Western blotting, immunoprecipitation, phosphorylation studies, and native-complex analysis. This workflow guide also explains how findings from a melatonin-loaded hydrogel study translate into better sample-preservation and assay-design decisions.
-
Diethylmaleate for Redox and GST Studies
2026-09-29
Diethylmaleate is an oxidative stress research chemical that connects controlled glutathione depletion with GST function, ROS signaling, apoptosis, and toxicant sensitivity. This guide translates evidence from insecticide-resistance research into practical cell, insect, and comparative redox workflows with built-in controls and troubleshooting steps.
-
Hypoxia-Activated Molecular Glue BNNC in Cancer Therapy
2026-09-29
The reference study introduces BNNC, a hypoxia-activated photomolecular glue designed to release the Cyclin K degrader (R)-CR8 together with the phototherapeutic agent BSS-Et in tumors. Its combined activity enhanced DNA damage and apoptosis in breast cancer models while showing tumor growth inhibition and favorable preliminary biosafety, offering a strategy for improving the selectivity of molecular glue therapy.
-
Amyloid Beta-peptide (25-35): Assay Logic
2026-09-28
Amyloid Beta-peptide (25-35) is a focused tool for modeling amyloid-driven neuronal injury and inflammatory signaling. This article explains how to use Aβ25-35 to separate aggregation, mitochondrial stress, microglial regulation, and tau phosphorylation kinase investigation in interpretable assays.
-
Reading P2RX1-Driven Apoptosis in Ph+ ALL
2026-09-28
A translational guide to interpreting P2RX1-linked cell death in Philadelphia chromosome-positive ALL, pairing mechanistic readouts with practical Annexin V-Cy5/DAPI assay design—and clarifying what the assay can and cannot establish.
-
DFCP1 Restrains Starvation-Driven ATGL Lipolysis
2026-09-27
The study identifies DFCP1/ZFYVE1 as a nutrient-sensitive regulator of lipid-droplet breakdown: during starvation, it recruits ATGL to droplets but limits ATGL’s dynamic dissociation, slowing lipolysis. This distinction between enzyme recruitment and enzyme activity helps explain how DFCP1 can influence lipid-droplet metabolism without simply acting as an ATGL activator.
-
Protease Inhibitor Cocktail for Skin-Model Assays
2026-09-26
Preserve protein signals from atopic dermatitis models without adding EDTA to workflows that depend on divalent cations. This guide connects a melatonin-loaded hydrogel study to practical lysate preparation, assay selection, and troubleshooting—while distinguishing sample protection from therapeutic mechanism.